Addressing Cannabis Hyperemesis Syndrome in Canada
- Cannabis
- Substance Use Costs
- Psychedelics
Read this evidence brief
About this evidence brief
Highlights key information on Cannabinoid Hyperemesis Syndrome (CHS) in Canada, an underrecognized condition that is linked to frequent cannabis use and exposure to high-THC products and can result in repeated episodes of severe nausea, vomiting, and abdominal pain. These brief covers commonly asked questions about CHS is, who is most affected, and the reason cannabis-related vomiting is leading to an increase in emergency care, while also highlighting the negative effects on Canada’s health care system.
In this brief, you will find:
- An explanation of CHS, including how it develops and key risk factors
- Trends related to cannabis-associated vomiting and emergency department use in Canada
- Considerations to promote awareness, timely diagnosis, and appropriate care
Related Authors
Justine Renard, PhD
Senior Research and Policy Analyst
Area of Expertise
- Cannabis
- Vaping